ATE98652T1 - Chemische derivate von ghl-cu. - Google Patents

Chemische derivate von ghl-cu.

Info

Publication number
ATE98652T1
ATE98652T1 AT86101456T AT86101456T ATE98652T1 AT E98652 T1 ATE98652 T1 AT E98652T1 AT 86101456 T AT86101456 T AT 86101456T AT 86101456 T AT86101456 T AT 86101456T AT E98652 T1 ATE98652 T1 AT E98652T1
Authority
AT
Austria
Prior art keywords
derivatives
ghl
useful
making
chemical derivatives
Prior art date
Application number
AT86101456T
Other languages
English (en)
Inventor
Loren Ralph Pickart
Original Assignee
Procyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procyte Corp filed Critical Procyte Corp
Application granted granted Critical
Publication of ATE98652T1 publication Critical patent/ATE98652T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT86101456T 1985-02-08 1986-02-05 Chemische derivate von ghl-cu. ATE98652T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/699,824 US4665054A (en) 1985-02-08 1985-02-08 Chemical derivatives of GHL-Cu
EP86101456A EP0190736B1 (de) 1985-02-08 1986-02-05 Chemische Derivate von GHL-Cu

Publications (1)

Publication Number Publication Date
ATE98652T1 true ATE98652T1 (de) 1994-01-15

Family

ID=24811059

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86101456T ATE98652T1 (de) 1985-02-08 1986-02-05 Chemische derivate von ghl-cu.

Country Status (6)

Country Link
US (1) US4665054A (de)
EP (1) EP0190736B1 (de)
JP (1) JPH0742311B2 (de)
AT (1) ATE98652T1 (de)
CA (1) CA1294738C (de)
DE (1) DE3689380T2 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937230A (en) * 1985-01-24 1990-06-26 Procyte Corporation Method of healing wounds in horses
US4810693A (en) * 1985-02-08 1989-03-07 Procyte Corporation Method for inducing biological coverings in wounds
US5214032A (en) * 1985-02-08 1993-05-25 Procyte Corporation GHL-CU pharmaceutical compositions and compounds
US5177061A (en) * 1985-02-08 1993-01-05 Procyte Corporation Method for stimulating hair growth using GHL-Cu complexes
US5550183A (en) * 1985-02-08 1996-08-27 Procyte Corporation Metal-peptide compositions and methods for stimulating hair growth
US5348943A (en) * 1985-02-08 1994-09-20 Procyte Corporation Cosmetic and skin treatment compositions
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
US4877770A (en) * 1985-02-08 1989-10-31 Procyte Corporation Chemical derivatives of GHL-Cu
US4767753A (en) * 1985-02-08 1988-08-30 Procyte Corporation Methods and compositions for preventing ulcers
US5470876A (en) * 1985-07-18 1995-11-28 Proctor; Peter H. Topical sod for treating hair loss
EP0288278B1 (de) * 1987-04-20 1994-03-30 Procyte Corporation Chemische Derivate von GHL-Cu
MX169205B (es) * 1987-05-11 1993-06-24 Procyte Corp Composicion para estimular el crecimiento del cabello
AU633005B2 (en) * 1988-06-16 1993-01-21 Procyte Corporation Cosmetic and skin treatment compositions
US5023237A (en) * 1989-08-30 1991-06-11 Procyte Corporation Methods and compositions for healing ulcers
US5145838A (en) * 1989-08-30 1992-09-08 Procyte Corporation Methods and compositions for healing ulcers
US5059588A (en) * 1989-10-13 1991-10-22 Procyte Corporation, Incorporated Methods and compositions for healing bone using gly his lys: copper
SE465154B (sv) * 1990-02-06 1991-08-05 Lars Strid Tillvaextfaktor i samband med artificiella transplantat
US5386012A (en) * 1990-02-06 1995-01-31 Strid; Lars Growth factor in connection with artificial implants
US5118665A (en) * 1990-02-09 1992-06-02 Procyte Corporation Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
US5164367A (en) * 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
US5252559A (en) * 1991-08-20 1993-10-12 The Procter & Gamble Company His-Gly-Gly peptide and derivatives thereof for hair growth
US5382431A (en) * 1992-09-29 1995-01-17 Skin Biology, Inc. Tissue protective and regenerative compositions
JPH078217U (ja) * 1993-07-14 1995-02-03 小倉美術印刷株式会社 瓶類の包装用箱
WO1995026192A1 (en) * 1994-03-28 1995-10-05 Skin Biology, Inc. Starch-metal complexes for skin and hair
US5538945A (en) * 1994-06-17 1996-07-23 Procyte Corporation Stimulation of hair growth by peptide copper complexes
US5888522A (en) * 1996-08-23 1999-03-30 Skin Biology, Inc. Tissue protective and regenerative compositions
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US7592304B2 (en) * 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
JP5349722B2 (ja) 1999-10-01 2013-11-20 ディーエムアイ バイオサイエンシズ インコーポレイテッド 金属結合化合物およびその使用方法
WO2003030926A1 (en) * 2001-10-05 2003-04-17 Procyte Corporation Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom
WO2004014413A1 (en) * 2002-07-31 2004-02-19 Procyte Corporation Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto
US20040142853A1 (en) * 2002-11-07 2004-07-22 Procyte Corporation Stimulation of hair growth by compositions containing peptide copper complexes and minoxidil
US20040138103A1 (en) * 2002-11-07 2004-07-15 Procyte Corporation Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
US7128923B2 (en) * 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
US6927205B2 (en) 2003-04-28 2005-08-09 Procyte Corporation Compositions and methods for treatment of psoriasis
US7521477B2 (en) * 2003-04-30 2009-04-21 Peptron Co., Ltd. Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same
US20040247633A1 (en) * 2003-06-04 2004-12-09 Ebersytes, Llc Novel dermatological composition
US6927206B2 (en) * 2003-06-06 2005-08-09 Procyte Corporation Compositions and methods for treatment of rosacea
US8734421B2 (en) * 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
FR2857597B1 (fr) * 2003-07-18 2008-01-25 Inst Europeen Biolog Cellulair Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie.
US20050260275A1 (en) * 2004-04-01 2005-11-24 Procyte Corporation Encapsulated peptide copper complexes and compositions and methods related thereto
US20060052287A1 (en) * 2004-08-18 2006-03-09 Procyte Corporation Polyethylene glycol - peptide copper complexes and compositions and methods related thereto
US20060216258A1 (en) 2005-03-24 2006-09-28 Singleton Laura C Water-in-silicone emulsion compositions
PL1993569T3 (pl) 2006-02-03 2014-11-28 Obagi Cosmeceuticals Llc Terapia przeciw starzeniu z użyciem kompozycji miedzi i cynku
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
KR100691540B1 (ko) 2006-06-22 2007-03-12 주식회사 펩트론 펩타이드가 결합된 안정화된 비타민 ｃ 유도체, 이의제조방법 및 이를 함유하는 조성물
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US20100209515A1 (en) * 2007-09-28 2010-08-19 Jeannette Chantalat Electricity-generating particulates and the use thereof
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US20100082088A1 (en) * 2008-08-27 2010-04-01 Ali Fassih Treatment of sweating and hyperhydrosis
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
EP2542209A1 (de) 2010-03-01 2013-01-09 Johnson & Johnson Consumer Companies, Inc. Hautpflegezusammensetzung mit erwünschter farbe in loser form
US20110236491A1 (en) * 2010-03-25 2011-09-29 Jeannette Chantalat Topical anti-inflammatory composition
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
ITRM20130199A1 (it) 2013-04-03 2014-10-04 Irbm Science Park S P A Peptidi per uso dermatologico e/o cosmetico

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591648A (en) * 1981-04-01 1986-05-27 National Research Development Corp. Histidine protection

Also Published As

Publication number Publication date
EP0190736A2 (de) 1986-08-13
DE3689380T2 (de) 1994-04-07
DE3689380D1 (de) 1994-01-27
EP0190736B1 (de) 1993-12-15
JPS61191694A (ja) 1986-08-26
EP0190736A3 (en) 1988-10-26
US4665054A (en) 1987-05-12
CA1294738C (en) 1992-01-21
JPH0742311B2 (ja) 1995-05-10

Similar Documents

Publication Publication Date Title
ATE98652T1 (de) Chemische derivate von ghl-cu.
FR2588189B1 (fr) Composition pharmaceutique de type a transition de phase liquide-gel
DE3787356D1 (de) Expression von höheren eukaryotischen genen in aspergillus.
CA1268123C (en) DIETARY PRODUCTS CONTAINING METHYLSULFONYLMETHANE AND THEIR USE
DE3689974D1 (de) Arzneimittel zur Behandlung von Emesis.
ATE84681T1 (de) Karrageenan enthaltendes waessriges gel.
DE69725293D1 (de) N-(2 oxoacetyl oder sulphonyl)-pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität
ATE59845T1 (de) Pflanzenschuetzende mittel auf basis von 1,2,4triazolderivaten sowie neue derivate des 1,2,4triazols.
DE3587741D1 (de) Behandlung von Hautkrankheiten.
DE3588023D1 (de) Mittel zur Behandlung von Herzerkrankungen.
DE3771146D1 (de) Pyrimidinderivate, ihre herstellung und medikamente, die diese derivate enthalten.
DE3684755D1 (de) Behandlung von tieren mit il-2, zubereitungen dafuer und ihre herstellung.
ATE67667T1 (de) Neue topische metronidazol-formulierungen.
DE3888718D1 (de) Chemische Derivate von GHL-Cu.
NO912435L (no) Farmasoeytiske preparater.
TR200100637T2 (tr) Yeni doğal ürün türevleri
DE3686245D1 (de) Amidderivate und antiallergische mittel, die sie enthalten.
DE3684213D1 (de) Tri-nickel-aluminid-zuammensetzungen und ihre behandlung zur erhoehung der widerstandsfaehigkeit.
IT1148273B (it) Composizione liquida per trattamento migliorativo di tessuti la quale contiene amido vegetale gelatinizzato,tensioattivo ed elettrolita
DE3882255D1 (de) Ein-schritt-enzymatische konversion von cephalosporin c und seiner derivate in 7-aminocephalosporinsaeure und derivate.
DE3679781D1 (de) Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung.
DE3771584D1 (de) Zusammensetzungen und anwendung von interleukin-2 und/oder interferon-beta und des tumor-necrosis-faktors fuer eine kombinationstherapie oder zur herstellung von arzneimitteln oder formulierungen.
ATE116850T1 (de) Mittel zur behandlung von erkrankungen der venen und des analbereichs.
FI863159A7 (fi) Sydänlääkkeinä käytettäviä heterosyklokarbonyyli- ja asetyylitiatsoloneja.
DE3767175D1 (de) Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee